In chronic immune responses and tumors, interferon-gamma (IFN-γ) produced by T cells induces the expression of PD-L1 at the antigen-presenting cells and tumor cells followed by down-regulation of the immune responses, which eventually yield to the failure of immunostimulants (7, 8). Here, IFNG is linked to neoplasm.